AU1953101A - Beta-3 adrenoceptor agonists - Google Patents

Beta-3 adrenoceptor agonists

Info

Publication number
AU1953101A
AU1953101A AU19531/01A AU1953101A AU1953101A AU 1953101 A AU1953101 A AU 1953101A AU 19531/01 A AU19531/01 A AU 19531/01A AU 1953101 A AU1953101 A AU 1953101A AU 1953101 A AU1953101 A AU 1953101A
Authority
AU
Australia
Prior art keywords
beta
adrenoceptor agonists
adrenoceptor
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19531/01A
Other languages
English (en)
Inventor
Kelly Horne Donaldson
Barry George Shearer
David Edward Uehling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU1953101A publication Critical patent/AU1953101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU19531/01A 1999-12-10 2000-12-08 Beta-3 adrenoceptor agonists Abandoned AU1953101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9929118 1999-12-10
GBGB9929118.9A GB9929118D0 (en) 1999-12-10 1999-12-10 Chemical compounds
PCT/US2000/033222 WO2001042217A1 (fr) 1999-12-10 2000-12-08 Agonistes du recepteur beta-3 adrenergique

Publications (1)

Publication Number Publication Date
AU1953101A true AU1953101A (en) 2001-06-18

Family

ID=10866004

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19531/01A Abandoned AU1953101A (en) 1999-12-10 2000-12-08 Beta-3 adrenoceptor agonists

Country Status (3)

Country Link
AU (1) AU1953101A (fr)
GB (1) GB9929118D0 (fr)
WO (1) WO2001042217A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995033724A1 (fr) * 1994-06-09 1995-12-14 Glaxo Group Limited Derives phenethanolamine et leur utilisation en tant qu'agonistes atypiques du recepteur adrenergique beta
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
GB9929118D0 (en) 2000-02-02
WO2001042217A1 (fr) 2001-06-14

Similar Documents

Publication Publication Date Title
AU3565800A (en) Can end
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU1548101A (en) Sphingosine derivatives
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU4974700A (en) Fluoroalkenyl nortropanes
AU2699800A (en) Organoceramics
AU5310500A (en) Pseudomycin prodrugs
AU2227901A (en) Surface-sizing agent
AU4396700A (en) Microbicidal composition
AU3775100A (en) Banners
AUPQ484599A0 (en) Reciprocating mechanism
AU1901801A (en) Glucofuranoses
AU1953101A (en) Beta-3 adrenoceptor agonists
AU6567400A (en) Substituted 2-imino-thiazolines
AU1915601A (en) Periotome
AU7303400A (en) Osseo-distractor
AU2582200A (en) Windturbine
AUPQ082799A0 (en) Fishing pliers
AU2197301A (en) Microlamp
AU2796700A (en) 4-phenoxymethyl-substituted milbemycins
AU2928500A (en) Wiper
AU6831100A (en) Substituted heterocyclybenzofuranes
AU5999100A (en) Cable holder

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase